BOMBESIN ANTAGONISTS

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$50,000.00
Award Year:
1992
Program:
SBIR
Phase:
Phase I
Contract:
n/a
Award Id:
18994
Agency Tracking Number:
18994
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
125 Michigan Avenue Ne, Washington, DC, 20017
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
Martha Knight
(800) 966-3384
Business Contact:
() -
Research Institute:
n/a
Abstract
RECENT BOMBESIN AND GASTRIN RELEASING PEPTIDE RECEPTOR ANTAGONISTS HAVE BEEN DEMONSTRATED TO B E QUITE POTENT IN INHIBITING THE EFFECTS OF BOMBESIN IN PANCREATIC ACINAR CELLS, BRAIN MEMBRANES, SWISS 3T3 FIBROBLASTS, AND HUMAN SMALL CELL LUNG CARCINOMA (SCLC). HOWEVER, THESE ANTAGONISTS DO NOT DISPLAY COMPARABLE HIGH POTENCY IN INHIBITING THE PROLIFERATION OF HUMAN SMALL CELL LUNG CARCINOMA. CERTAIN BOMBESIN ANTAGONISTS DO INHIBIT PROLIFERATION OF CLONAL GROWTH OF SCLC AND HAVE BEEN FOUND TO INHIBIT SCLC TUMOR GROWTH IN VIVO. STUDIES WILL BE CONDUCTED TO DESIGN AND SYNTHESIZE MORE STABLE COMPOUNDS FROM THE INHIBITOR STRUCTURES BY CYCLIZATION AND DESCREASING THEIR SUSCEPTIBILITY TO PROTEOLYTIC DEGRADATION. NOVEL GROUPS WILL BE ADDED TO THE ANTAGONISTS TO INCREASE INTERACTION WITH SCLC RECEPTOR. THE EFFECT ON CLONAL GROWTH OF HUMAN SCLC CELLS WILL BE MEASURED AS AN INDICATOR OF IN VIVO ANTI-TUMOR POTENTIAL.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government